Synthesis and evaluation of a radiometal-labeled macrocyclic chelator-derivatised thymidine analog

Nuclear Medicine and Biology

Volumn 33, Issue 3, 2006, Pages 359-366

  Schmid, Michaela ^a   Neumaier, Bernd ^a   Vogg, Andreas T J ^a   Wczasek, Katrin ^a   Friesen, Claudia ^a   Mottaghy, Felix M ^a   Buck, Andreas K ^a   Reske, Sven N ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Macrocyclic ligands; Nucleoside; Proliferation; Radiometals; Thymidine kinase 1

Indexed keywords

3 (5 1,4,7 TRIS(CARBOXYMETHYL 1,4,7,10 TETRAZACYCLODODECANE PENTYL)THYMIDINE IN 111; CHELATING AGENT; GALLIUM 68; INDIUM 111; MACROCYCLIC COMPOUND; RADIOPHARMACEUTICAL AGENT; THYMIDINE; THYMIDINE DERIVATIVE; THYMIDINE KINASE 1; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HL 60; CELL TRANSPORT; COMPLEX FORMATION; CONJUGATE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIPOPHILICITY; PHOSPHORYLATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

CHELATING AGENTS; GALLIUM RADIOISOTOPES; HETEROCYCLIC COMPOUNDS, 1-RING; HL-60 CELLS; HUMANS; INDIUM RADIOISOTOPES; LIGANDS; LYMPHOMA, B-CELL; PHOSPHORYLATION; SUBSTRATE SPECIFICITY; THYMIDINE; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 33646029107     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2005.12.010     Document Type: Article

References (25)

1. Hengstschläger M., Knöfler M., Müllner E.W., Ogris E., Wintersberger E., and Wawra E. Different regulation of thymidine kinase during the cell cycle of normal versus DNA tumor virus-transformed cells. J Biol Chem 269 (1994) 13836-13842
2. Al-Madhoun A.S., Johnsamuel J., Barth R.F., Tjarks W., and Eriksson E. Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy. Cancer Res 64 (2004) 6280-6286
3. Barth R.F., Yang W., Al-Madhoun A.S., Johnsamuel J., Byun Y., Chandra S., et al. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors. Cancer Res 64 (2004) 6287-6295
4. 68Ga-labelled DOTA-derivatised peptide ligands. Eur J Nucl Med Mol Imaging 31 (2004) 1097-1104
5. Diogo H.P., Dias A.R., Dhalla A., Minas da Piedade M.E., and Begley T.P. Mechanistic studies on DNA photolyase. 4. The enthalpy of cleavage of a model photodimer. J Org Chem 56 (1991) 7340-7341
6. Moerlein S.M., and Welch M.J. The chemistry of gallium and indium as related to radiopharmaceutical production. Int J Nucl Med Biol 8 (1981) 277-287
7. 4). Appl Radiat Isot 62 (2005) 711-720
8. Adams D.R., Perez C., Maillard M., Florent J.-C., Evers M., Henin Y., et al. Preparation and anti-HIV activity of N-3-substituted thymidine nucleoside analogs. J Med Chem 40 (1997) 550-1558
9. Al-Madhoun A.S., Tjarks W., and Eriksson S. The role of thymidine kinases in the activation of pyrimidine nucleoside analogues. Mini Rev Med Chem 4 (2004) 341-350
10. 177Lu at high specific activities. Eur J Nucl Med Mol Imaging 30 (2003) 917-920
11. 68Ga bioconjugates with high specific radioactivity. Bioconjug Chem 15 (2004) 554-560
12. Szilagyi E., Toth E., Kovacs Z., Platzek J., Radüchel B., and Brücher E. Equilibria and formation kinetics of some cyclen derivative complexes of lanthanides. Inorg Chim Acta 298 (2000) 226-234
13. Ruser G., Ritter W., and Maecke H.R. Synthesis and evaluation of two new bifunctional carboxymethylated tetraazamacrocyclic chelating agents for protein labeling with indium-111. Bioconjug Chem 1 (1990) 345-349
14. Shannon R.D. Revised effective ionic radii and systemic studies of interatomic distances in halides and chalkogenides. Acta Cryst A32 (1976) 751-767
15. Liu S. The role of coordination chemistry in the development of targetspecific radiopharmaceuticals. Chem Soc Rev 33 (2004) 445-461
16. 111In-labeled DOTA-biomolecule conjugates. Inorg Chem 42 (2003) 8831-8837
17. 111In-labeled DTPA peptide conjugates. Bioconjug Chem 12 (2001) 630-634
18. Heppeler A., Froidevaux S., Maecke H.R., Jermann E., Behe M., Powell P., et al. Radiometal-labelled macrocyclic chelator-derivatised somatostatin analogue with superb tumor-targeting properties and potential for receptor-mediated internal radiotherapy. Chem Eur J 5 (1999) 1974-1981
19. 3+ complexes with relevance to radiopharmaceutical applications. J Chem Soc Chem Commun 8 (1989) 460-462
20. Shields A.F., Grierson J.R., Dohmen B.M., Machulla H.-J., Stayanoff J.C., Lawhorn-Crews J.M., et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 4 (1998) 1334-1336
21. 18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels. Eur J Nucl Med Mol Imaging 32 (2005) 257-263
22. Morin K.W., Duan W., Xu L., Zhou A., Moharram S., Knaus E.E., et al. Cytotoxicity and cellular uptake of pyrimidine nucleosides for imaging herpes simplex type-1 thymidine kinase (HSV-1 TK) expression in mammalian cells. Nucl Med Biol 31 (2004) 623-630
23. Kong X.B., Zhu Q.Y., Vidal P.M., Watanabe K.A., Polsky B., and Armstrong D. Comparions of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3′-fluoro-3′-deoxythymidine and 3′-azido-3′-deoxythymidine. Antimicrob Agents Chemother 36 (1992) 808-818
24. Arner E.S., and Eriksson S. Mammalian deoxyribonucleoside kinases. Pharmacol Ther 67 (1995) 155-186
25. 18F]FLT) as positron emission tomography tracer for imaging proliferation in a murine B-cell lymphoma model and in the human disease. Cancer Res 63 (2003) 2681-2687